NT5E and breast carcinoma: Collectively, these markers CD73+ and CD90+/CD105+ promote tumor growth, angiogenesis, and metastasis in breast cancer cells, and positive expression of these markers in PDOs was an indicator of the MSC phenotype of the original tumor.